Binding of artemether and lumefantrine to plasma proteins and erythrocytes

European Journal of Pharmaceutical Sciences

Volumn 9, Issue 1, 1999, Pages 9-16

  Colussi, Danielle ^a   Parisot, Carole ^a   Legay, François ^a   Lefèvre, Gilbert ^b  

^a NOVARTIS PHARMA K K   (Japan)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Artemether; Benflumetol; CGP 56697; Distribution; Erythrocyte partitioning method; Lumefantrine; Protein binding; Ultrafiltration

Indexed keywords

ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; BENFLUMETOL; HIGH DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG DISTRIBUTION; ERYTHROCYTE; HUMAN; HUMAN CELL; METHODOLOGY; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; ANTIMALARIALS; ARTEMISININS; BLOOD PROTEINS; DOGS; ERYTHROCYTES; ETHANOLAMINES; FLUORENES; HUMANS; MICE; PROTEIN BINDING; RABBITS; RATS; SESQUITERPENES; ULTRAFILTRATION;

EID: 0032860379     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(99)00037-8     Document Type: Article

References (16)

1. Asawamahasakda W., Benakis A., Meshnick S. The interaction of artemisinin with red cell membranes. J. Lab. Clin. Med. 123:(5):1994;757-762.
2. Colussi D., Parisot C., Lefèvre G. Binding of iralukast to serum proteins and erythrocytes: Measurements using ultrafiltration and an erythrocyte partitioning method. Eur. J. Pharmac. Sci. 7:1998;167-173.
3. Hatz C., Abdulla S., Mull R., Schellenberg D., Gathmann I., Kibatala P., Beck H.-P., Tanner M., Royce C. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years. Trop. Med. Int. Health. 3:(6):1998;498-504.
4. Karbwang J., Na-Bangchang K., Congpuong K., Molunto P., Thanavibul A. Pharmacokinetics and bioavailability of oral and intramuscular artemether. Eur. J. Clin. Pharmacol. 52:1997;307-310.
5. Li W., Shu H., Xu G., Zeng Y. The binding of qinghaosu (artemisinine) and its derivatives to plasma protein. Acta Pharm. Sin. 17:1982;783-786.
6. 14C-dihydroartemisinin to human and animal plasma protein. Clin. Pharmacol. Therapeut. 55:(2):1994;166.
7. Mansor S., Navaratnam V., Yahaya N., Nair N., Wernsdorfer W., Degen P. Determination of a new antimalarial drug, benflumetol, in blood plasma by high-performance liquid chromatography. J. Chromatogr. B. 682:1996;321-325.
8. Maulard C., Urien S., Bastian G., Tillement J.P. Binding of retelliptine, a new antitumoral agent, to serum proteins and erythrocytes. Biochem. Pharmacol. 40:(4):1990;895-898.
9. Morin D., Zini R., Ledewyn S., Colonna J., Czajka M., Tillement J.P. Binedaline binding to plasma proteins and red blood cells in humans. J. Pharm. Sci. 74:(7):1985;727-730.
10. Muret P., Makki S., Urien S., Agache P., Bechtel P., Tillement J.P. Binding of 5-methoxypsoralen to blood fractions. Skin Pharmacol. 6:1993;45-51.
11. Roos A., Hinderling P. Protein binding and erythrocyte partitioning of the antirheumatic proquazone. J. Pharm. Sci. 70:(3):1981;252-257.
12. Thomsen, M.S., Lefèvre, G., Ezzet, F., Bindschedler, M., Co-artemether: Pharmacokinetic profile of a combined anti-malaria compound treatment, 2nd European Congr. on Tropical Medicine, Liverpool, UK, 14-18 Sept., 1998, Poster presentation, Abstract P. 31.
13. Urien S., Riant P., Renouard A., Coulomb B., Rocher I., Tillement J.P. Binding of indapamide to serum proteins and erythrocytes. Biochem. Pharmacol. 37:(15):1988;2963-2966.
14. Urien S., Claudepierre P., Meyer J., Brandt R., Tillement J.P. Comparative binding of etretinate and acitretin to plasma proteins and erythrocytes. Biochem. Pharmacol. 44:(9):1992;1891-1893.
15. van Vugt M., Brockman A., Gemperli B., Luxemburger C., Gathmann I., Royce C., Slight T., Looareesuwan S., White N.J., Nosten F. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob. Agents Chemother. 42:(1):1998;135-139.
16. von Seidlein L., Jaffar S., Pinder M., Haywood M., Snounou G., Gemperli B., Gathmann I., Royce C., Greenwood B. Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697. J Infect. Dis. 176:(4):1997;1113-1116.